We are live on ! Find out more
RPID icon

Rapid Micro Biosystems

42 hedge funds and large institutions have $42.5M invested in Rapid Micro Biosystems in 2025 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

650% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 2

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

45% more funds holding

Funds holding: 2942 (+13)

0.63% less ownership

Funds ownership: 37.34%36.71% (-0.63%)

14% less capital invested

Capital invested by funds: $49.5M → $42.5M (-$7.02M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
42
Holders Change
+13
Holders Change %
+44.83%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
15
Increased
11
Reduced
7
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$24.5M
AWGLSCP
2
ABG-WTT Global Life Science Capital Partners
Hong Kong
$5.36M
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.84M +$47.8K +13,763 +1%
AI
4
Advent International
Massachusetts
$1.68M
PHP
5
Parkman Healthcare Partners
Connecticut
$1.03M -$1.94M -558,978 -61%
SSA
6
Schonfeld Strategic Advisors
New York
$1.02M -$1.02M -294,146 -45%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$631K +$44.7K +12,881 +6%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$499K +$395K +113,848 +195%
EFA
9
Evernest Financial Advisors
Indiana
$469K -$261K -75,234 -38%
BlackRock
10
BlackRock
New York
$454K -$1.14M -327,205 -68%
Citadel Advisors
11
Citadel Advisors
Florida
$367K +$439K +126,539 New
6CM
12
683 Capital Management
New York
$350K +$419K +120,773 New
Millennium Management
13
Millennium Management
New York
$338K +$405K +116,502 New
Renaissance Technologies
14
Renaissance Technologies
New York
$335K +$18.9K +5,440 +5%
Jane Street
15
Jane Street
New York
$305K +$233K +67,161 +176%
SEI Investments
16
SEI Investments
Pennsylvania
$271K +$325K +93,616 New
State Street
17
State Street
Massachusetts
$265K
EI
18
EAM Investors
California
$224K +$268K +77,182 New
Marshall Wace
19
Marshall Wace
United Kingdom
$182K +$218K +62,911 New
EIM
20
Essex Investment Management
Massachusetts
$181K
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$162K +$1.88K +540 +1%
Goldman Sachs
22
Goldman Sachs
New York
$160K +$192K +55,306 New
Northern Trust
23
Northern Trust
Illinois
$117K -$25.1K -7,239 -15%
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
$96K +$115K +33,099 New
Morgan Stanley
25
Morgan Stanley
New York
$91K +$37.6K +10,839 +53%

RPID Hedge Fund Activity: Q4 2025 in Review

42 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q4 2025, worth a combined $42.5M — down 14% from $49.5M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new RPID positions and 2 closed out — a net gain of 13 holders — while 11 added to existing stakes and 7 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $439K. The largest seller was Parkman Healthcare Partners, cutting an estimated $1.94M.

  • 42 institutional investors held Rapid Micro Biosystems (RPID) as of Q4 2025, up from 29 in Q3 2025.
  • Funds reported $42.5M of Rapid Micro Biosystems stock for Q4 2025, down 14% quarter-over-quarter.
  • 15 funds opened new Rapid Micro Biosystems positions in Q4 2025 and 2 closed out, a net change of +13 holders.
  • The largest Rapid Micro Biosystems buyer in Q4 2025 was Citadel Advisors, an estimated $439K added.
  • The largest Rapid Micro Biosystems seller in Q4 2025 was Parkman Healthcare Partners, an estimated $1.94M sold.

Based on aggregated 13F filings for Q4 2025.